CDC logo
Safer Healthier People
CDC Home CDC Search CDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Skip navigation links Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us

Search for NIOSH Publications: NIOSHTIC-2

NIOSHTIC-2 Search Results

      Advanced Search  |  Help  |  About  |  Feedback 
Terms: 20037797
1 - 1 of 1 Bibliographic entries
All record(s) shown.
Save All   |   Save Page
View Saved    |    Download
Select check boxes to automatically save entries, or use 'save all' or 'save page' links above.
Back to Results
Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers.
Authors
Connor-TH; DeBord-DG; Pretty-JR; Oliver-MS; Roth-TS; Lees-PSJ; Krieg-EF Jr; Rogers-B; Escalante-CP; Toennis-CA; Clark-JC; Johnson-BC; McDiarmid-MA
Source
J Occup Environ Med 2010 Oct; 52(10):1019-1027
Link
http://dx.doi.org/10.1097/JOM.0b013e3181f72b63 
NIOSHTIC No.
20037797 
Abstract
Objective: This study evaluated health care worker exposure to antineoplastic drugs. Methods: A cross-sectional study examined environmental samples from pharmacy and nursing areas. A 6-week diary documented tasks involving those drugs. Urine was analyzed for two specific drugs, and blood samples were analyzed by the comet assay. Results: Sixty-eight exposed and 53 nonexposed workers were studied. Exposed workers recorded 10,000 drug-handling events during the 6-week period. Sixty percent of wipe samples were positive for at least one of the five drugs measured. Cyclophosphamide was most commonly detected, followed by 5-fluorouracil. Three of the 68 urine samples were positive for one drug. No genetic damage was detected in exposed workers using the comet assay. Conclusions: Despite following recommended safe-handling practices, workplace contamination with antineoplastic drugs in pharmacy and nursing areas continues at these locations.
Keywords
Biological-factors; Biological-monitoring; Biological-systems; Biological-transport; Biomarkers; Cancer-rates; Carcinogenesis; Carcinogenicity; Carcinogens; Chemical-hypersensitivity; Drugs; Epidemiology; Exposure-assessment; Exposure-levels; Physiological-effects; Physiological-factors; Physiological-response; Reproductive-hazards; Reproductive-system-disorders; Risk-analysis; Risk-factors; Safety-measures; Statistical-analysis; Teratogenesis; Teratogens; Work-analysis; Work-areas; Work-environment; Worker-health; Work-operations; Work-performance; Workplace-studies; Work-practices
Contact
Thomas H. Connor, National Institute for Occupational Safety and Health, DART, Centers for Disease Control and Prevention, MS C-23,4676 Columbia Pkwy, Cincinnati, OH 45226
CODEN
JOEMFM
Publication Date
20101001
Document Type
Journal Article
Email Address
tmc6@cdc.gov
Fiscal Year
2011
NTIS Accession No.
NTIS Price
Issue of Publication
10
ISSN
1076-2752
NIOSH Division
DART
Source Name
Journal of Occupational and Environmental Medicine
State
OH; MD; NC; TX
Page 1 of 1
All record(s) shown.

File Formats Help:

Adobe PDF file
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?double arrows.